UBS Group’s Frontline FRO Stock Holding History

UBS Group’s Portfolio FRO Stock Details FRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-27,320	Closed	-$408K	–	7809
2015 Q4	$408K	Sell	27,320 -1,680	-6%	-$25.6K	﹤0.01%	4120
2015 Q3	$390K	Hold	29,000	–	–	﹤0.01%	4108
2015 Q2	$354K	Sell	29,000 -1,140	-4%	-$15.2K	﹤0.01%	4393
2015 Q1	$338K	Sell	30,140 -110,340	-79%	-$1.54M	﹤0.01%	4444
2014 Q4	$1.76M	Buy	+140,480	New	+$1.14M	﹤0.01%	3021

Other funds holding FRO

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group's FRO Position: Q1 2026 in Review

UBS Group increased its Frontline (FRO) stake by 78% in Q1 2026, buying an estimated $33.6M and bringing the position to 2,512,285 shares worth $87.6M. The position accounts for 0.01% of the portfolio, ranked #1150.

UBS Group first reported a position in FRO in Q4 2014 and has held it in 46 quarters since. 239 funds tracked by Wall St. Rank hold FRO as of Q1 2026.

UBS Group held 2,512,285 shares of Frontline worth $87.6M as of Q1 2026.
UBS Group bought 1,101,020 Frontline shares in Q1 2026, an estimated $33.6M.
Frontline made up 0.01% of UBS Group's portfolio in Q1 2026, its #1150 holding.
UBS Group first reported a position in Frontline in Q4 2014 and has held it in 46 quarters since.
239 funds tracked by Wall St. Rank held Frontline as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.